Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic syndrome
Acta Biochimica Polonica · 14.07.2026 · 73
DOI: 10.3389/abp.2026.16873 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biochimica Polonica, online erschienen am 14.07.2026. Verfasst von Marcin L Kutek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Embryology, Medical University of Gdańsk, Gdańsk, Poland. Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, Metabolic Syndrome. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardio-renal-metabolic syndrome (CRMS)—characterized by the pathological interplay of visceral adiposity, insulin resistance, chronic kidney disease, and cardiovascular disease—affects over 90% of US adults across its staging spectrum, yet its multi-organ burden remains difficult to assess non-invasively at the point of care. This narrative mini review examines whether multiparametric ultrasound within a single examination can serve as an integrated imaging biomarker set complementary to established molecular markers of CRMS. A narrative search of PubMed (2015–2026) was conducted using PICO-structured queries. The hepatic controlled attenuation parameter and liver stiffness measurement correlate directly with Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), CRP, and adipokine dysregulation, with pooled CAP cutoffs of 268–313 dB/m and elastography thresholds of 8.2–13.6 kPa for fibrosis staging in MASLD. Epicardial adipose tissue thickness correlates with circulating IL-17A (r = 0.308), hs-CRP (r = 0.666), and HOMA-IR (r = 0.567–0.580), independently predicting left ventricular diastolic dysfunction beyond BMI. Carotid intima-media thickness tracks eGFR decline longitudinally and predicts cardiovascular mortality in CKD populations. Renal resistive index, with a validated threshold of ≥0.70, independently predicts GFR decline and cardiovascular mortality across diabetic and hypertensive populations. Renal shear wave elastography distinguishes fibrotic from non-fibrotic parenchyma, with 93.1% sensitivity against biopsy. Cross-compartmental correlations and composite imaging-biochemistry models consistently outperform single-parameter approaches. Two critical gaps remain: specific ultrasound values have not been associated with AHA/ACC CKM stages, and no outcome study has validated a multiorgan protocol. Multiparametric ultrasound provides a clinically feasible, evidence-based CRMS assessment that remains to be validated in prospective trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Embryology, Medical University of Gdańsk, Gdańsk, Poland.
- Department of Physiopathology, Medical University of Gdańsk, Gdańsk, Poland.
- Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.
Zitieren
APA
Kutek, M. L., & Witkowski, J. M. (2026). Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic syndrome. Acta Biochimica Polonica, 73. https://doi.org/10.3389/abp.2026.16873
Vancouver
Kutek ML, Witkowski JM. Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic syndrome. Acta Biochimica Polonica. 2026;73. doi:10.3389/abp.2026.16873
BibTeX
@article{Kutek2026,
author = {Kutek, Marcin L and Witkowski, Jacek M},
title = {Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic syndrome},
journal = {Acta Biochimica Polonica},
year = {2026},
volume = {73},
doi = {10.3389/abp.2026.16873}
}
EUVIMED